The rise of telepharmacy services during the COVID-19 pandemic: A comprehensive assessment of services in the United Arab Emirates

• Feras Jirjees ^[1] ; Mohanad Odeh ^[2] ; Lynn Aloum ^[3] ; Zelal Kharaba ^[4] ; Karem H Alzoubi ^[4] ; Hala J. Al-OBAIDI ^[5]
  1. [1] University of Sharjah

     University of Sharjah

     Emiratos Árabes Unidos

     
  2. [2] Hashemite University

     Hashemite University

     Jordania

     
  3. [3] Kingston University

     Kingston University

     Kingston upon Thames, Reino Unido

     
  4. [4] College of Pharmacy, Al-Ain University, UAE, Faculty of Medical Sciences, Newcastle University, UK.
  5. [5] College of Pharmacy and Health Sciences, Ajman University, UAE.

  Mostrar afiliaciones +
• Localización: Pharmacy Practice (Granada), ISSN-e 1886-3655, Vol. 20, Nº. 2, 2022 (Ejemplar dedicado a: Apr-Jun)
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Objective: The study aimed to explore changes in community pharmacies’ processes in response to the pandemic in the United Arab Emirates (UAE) and factors affecting the adoption of these changes.

    Method: A cross-sectional study was conducted using a self-administered questionnaire that was distributed to licensed community pharmacists in the UAE. The survey used to collect information on the type of telepharmacy services and related topics such as constraints and supports. The evaluation of services was done for three periods: before, during and after lockdown.

    Results: The number of completed surveys was 391. The majority of the participants were under 35 years old (79.5%), female (65.0%), with a bachelor’s degree (82.6%), and working in a pharmacy group (70.6%). Pharmacies provided the services by phone (95.6%) and/or messaging applications (80.0%) such as WhatsApp and Messenger. The community pharmacies provided a variety of services using telepharmacy tools such as managing of mild diseases, dispensing and delivering prescribed and OTC medications, general health information, and services for patients with chronic disease. The main factors that had significant effects on several telepharmacy services were pharmacies’ type (group/chain vs. individual) and the number of pharmacists in the pharmacy (p < 0.05). Lack of time, training and financial support were the main barriers associated with telepharmacy services among individual pharmacies.

    Conclusion: Telepharmacy supported the work of community pharmacies during the COVID-19 pandemic by facilitating the provision of pharmaceutical services. Although the occurrence of several financial and technical problems, it appeared less frequently in pharmacy chains with a large number of pharmacists.